Sign in
4

Changes in Ownership

SAB Biotherapeutics, Inc. Filed Acc 0000950170-23-054936

Options or other derivatives

  • Director acquired 16,269 shares (grant or award)
  • Director acquired 16,269 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Moin Andrew Director 2023-10-23 Grant or award · Series A-1 Convertible Preferred Stock +16,269 $1,000.00 $16,269,000 18,000 I
Moin Andrew Director 2023-10-23 Option exercise · Preferred Tranche A Warrants −16,269 0 I
Loading xslF345X05/ownership.xml…